Associations of Gender and Age with the Reporting of Drug‐Induced Hepatic Failure: Data from the VigiBase™

Citations Over TimeTop 10% of 2013 papers

Abstract

Patient gender and age are considered to be the risk factors for developing drug-induced liver injury (DILI). The aim of this study was to analyze gender and age differences in reporting of drug-induced hepatic failure (HF) to the VigiBase™. VigiBase™ was screened for the HF reports submitted from 2000 to 2009. The information retrieved referred to the suspected drug, age, gender, and a reporting country. Variables were examined by using descriptive statistics and the binomial test. During the 10-year period there were in total 6,370 HF reports from 38 countries. After the exclusion of cases with missing gender data (379 cases), females counted for 54.03%. The largest portion of HF cases referred to age <55 (42.57%) with female predominance (56.81%), whereas age ≥55 (32.57%) showed almost even gender distribution. Overall, there were 941 different drugs or their combinations reported. Females significantly predominated in HF cases associated with analgesics, antiepileptics, antiinflamatory and antirheumatic drugs, psychoanaleptics, antibacterials for systemic use, and antidiabetic drugs. Males were significantly overrepresented in HF cases associated with antivirals for systemic use. Differences between genders and/or age groups in the reporting of drug-induced HF depend on drug and/or drug class but may be influenced by multiple factors.

Related Papers

• → Co-Prescription Trends in a Large Cohort of Subjects Predict Substantial Drug-Drug Interactions(2015)51 cited
• → Exploring the potential for using drug indications to prevent look-alike and sound-alike drug errors(2017)13 cited
• → An update on drug-induced arthritis(2016)12 cited
• Susquehanna Chorale Spring Concert "Roots and Wings"(2017)
• → Genentech taps Affimed’s antibodies(2018)